NCPA orchestrated a sign-on letter to CMS seeking an opportunity to meet regarding the requirement for the Department of Health and Human Services to formulate the specific "reasonable and relevant" contract terms that prescription drug plan (PDP) sponsors will be required to offer pharmacies under the new PBM reform law. For details on the new law, including the reasonable and relevant provisions, click here.
NCPA was joined by the American Pharmacists Association, the National Association of Chain Drug Stores, the American Society of Consultant Pharmacists, the National Association of Specialty Pharmacy, FMI — The Food Industry Association, and the National Grocers Association in seeking a meeting.
According to the law, the secretary of Health and Human Services will formulate the specific "reasonable and relevant" contract terms that PDP sponsors will be required to offer pharmacies. The secretary must also issue a request for information from the public seeking input on what constitutes reasonable and relevant terms by April 1, 2027. The secretary must establish "reasonable and relevant" terms by April 3, 2028, so they can be included in the PDP sponsor contracts offered to network pharmacies in spring 2028 for the 2029 Part D plan year.
NCPA is in the process of scheduling this meeting with CMS and will keep members posted on developments.
